RE: Topped up again .7 Feb 2025 14:45
If P140 is granted 'Orphan Drug Designation' and fast-track approval, expediting its path to market and extending market exclusivity, we could see a multi multi bagger in the offering - having researched & taken an interest in the treatment for Lupus, which would be fantastic news for those affected, and other treatment options etc, news now is the key & personally I don't think that is far away.
Whatever the option taken by IMM the outcome can now only be positive for the investors here - or lets hope so !!
GLA